Evidence map›Paper›PMID 35123651›Full record

ArticleCell2022

Cryo-ET of Env on intact HIV virions reveals structural variation and positioning on the Gag lattice.

Vidya Mangala Prasad, Daniel P Leaman, Klaus N Lovendahl, Jacob T Croft, Mark A Benhaim, Edgar A Hodge, Michael B Zwick, Kelly K Lee

Open access · hybridAbstract read
In one paragraph

Article in Cell, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
6.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 91 citations in OpenAlex.

  1. Mechanisms of HIV-1 assembly, release and maturation.Nature reviews. Microbiology · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Vidya Mangala PrasadDepartment of Medicinal Chemistry, University of Washington, Seattle, WA 98195, USA.
Daniel P LeamanDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Klaus N LovendahlDepartment of Medicinal Chemistry, University of Washington, Seattle, WA 98195, USA.
Jacob T CroftDepartment of Medicinal Chemistry, University of Washington, Seattle, WA 98195, USA.
Mark A BenhaimDepartment of Medicinal Chemistry, University of Washington, Seattle, WA 98195, USA.
Edgar A HodgeDepartment of Medicinal Chemistry, University of Washington, Seattle, WA 98195, USA.
Michael B ZwickDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA. Electronic address: zwick@scripps.edu.
Kelly K LeeDepartment of Medicinal Chemistry, University of Washington, Seattle, WA 98195, USA; Biological Physics, Structure and Design Graduate Program, University of Washington, Seattle, WA 98195, USA; Department of Microbiology, University of Washington, Seattle, WA 98195, USA. Electronic address: kklee@uw.edu.
University of Washington · USScripps Research Institute · US

Funding

TRAINING IN MOLECULAR BIOPHYSICST32GM008268 · NIGMS · UNIVERSITY OF WASHINGTON · PI KOLLMAN, JUSTIN M, ZHENG, NING · 1988 to 2023
$8.6M
Structural and dynamic traits underlying phenotypic variation in HIV-1 EnvR01AI140868 · NIAID · UNIVERSITY OF WASHINGTON · PI Kelly Keisen Lee · 2019 to 2026
$5.3M
HIV-1 vaccine design emphasizing bnAb targets on membrane Env liposomesR01AI143563 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI ZWICK, MICHAEL B · 2019 to 2023
$4.0M
Waters ACQUITY UPLC M-Class with NanoLockSpray ionization sourceR01GM099989 · NIGMS · UNIVERSITY OF WASHINGTON · PI LEE, KELLY KEISEN · 2012 to 2020
$3.5M
Acquisition of a high resolution, high throughput cryo-electron microscopeS10OD023476 · OD · UNIVERSITY OF WASHINGTON · PI KOLLMAN, JUSTIN M · 2017 to 2017
$2.0M
NIAID NIH HHS R01 AI140868NIAID NIH HHS R01 AI143563NIGMS NIH HHS R01 GM099989NIGMS NIH HHS T32 GM008268NIH HHS S10 OD023476
6 · The paper itself

Abstract

HIV-1 Env mediates viral entry into host cells and is the sole target for neutralizing antibodies. However, Env structure and organization in its native virion context has eluded detailed characterization. Here, we used cryo-electron tomography to analyze Env in mature and immature HIV-1 particles. Immature particles showed distinct Env positioning relative to the underlying Gag lattice, providing insights into long-standing questions about Env incorporation. A 9.1-Å sub-tomogram-averaged reconstruction of virion-bound Env in conjunction with structural mass spectrometry revealed unexpected features, including a variable central core of the gp41 subunit, heterogeneous glycosylation between protomers, and a flexible stalk that allows Env tilting and variable exposure of neutralizing epitopes. Together, our results provide an integrative understanding of HIV assembly and structural variation in Env antigen presentation.

Indexed as

Cryoelectron MicroscopyElectron Microscope Tomography2,2'-DipyridylAmino Acid SequenceDisulfidesenv Gene Products, Human Immunodeficiency VirusEpitopesgag Gene Products, Human Immunodeficiency VirusHEK293 CellsHIV Envelope Protein gp41HumansHydrogen Deuterium Exchange-Mass SpectrometryModels, MolecularNeutralization TestsPeptidesPolysaccharides2,2'-Dipyridyl2,2'-dipyridyl disulfideDisulfidesenv Gene Products, Human Immunodeficiency VirusEpitopesgag Gene Products, Human Immunodeficiency VirusHIV Envelope Protein gp41PeptidesPolysaccharidesProtein Subunitsbroadly neutralizing antibodycryo-electron microscopycryo-electron tomographyGag-Env interactionHIV assemblyHIV Env glycoproteinhydrogen/deuterium-exchange mass spectrometrysub-tomogram averagingvaccine designvirus structure

Identifiers

PMID35123651
PMCPMC9000915
OpenAlexW4210661134

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.